Transforming the way medical products are developed, evaluated, and manufactured
The The U. S. Food and Drug Administration (FDA) defines Regulatory Science as “the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all FDA-regulated products.” The FDA has launched a number of programs to enhance the translation of research into products that benefit patients and improve the success rate of safe and effective products. More information can be obtained through the FDA's strategic plan which explains the vision and importance of this exciting new field
News and Funding Opportunities
The University of North Carolina at Chapel Hill and Wake Forest School of Medicine are seeking applications for 3 full-time post-doctoral fellowship positions. Candidates must have a doctoral degree in social or behavior science (or related field) and be interested in tobacco control research. View more information and instructions on how to apply. Applications are reviewed on a rolling basis and positions could start by August 2014.
On March 27, 2014, the Reagan-Udall Foundation for the FDA (RUF) announced the launch of a two-year fellowship in Alzheimer's Disease Regulatory Science. This opportunity is for MD's or DO's with several years of clinical experience working with patients with Alzheimer's Disease (AD). The fellowship focuses on identifying and creating opportunities for collaboration with AD scientific and patient advocacy communities to advance the development of new treatments. Applications are reviewed on a rolling basis with start dates between July and November 2014. For more information and how to apply, click here.
Want to see how your research can impact federal regulations? Want to discuss your ideas with the FDA? Join the "America's Got Regulatory Science Talent" Competition. For more general information, last year's announcement is available here.
The Innovation in Regulatory Science Awards provide $500,000 over five years to support investigators who are addressing research questions that will lead to innovation in Regulatory Science, with ultimate translation of those results into improving the regulatory process. The pre-proposal deadline is Novermber 18, 2013. For more information, click here.
FDA Priority Areas
The FDA has identified the following as examples of priority areas in its plans to advance Regulatory Science:
Ensuring Readiness to Evaluate Innovative and Emerging Technologies
Improving pre-Clinical Assessments of Safety and Efficacy
Improving Clinical Studies and Evaluation
Supporting New Approaches to Improving Product Manufacturing and Quality
Harnessing Diverse Data through Information Sciences to Improve Health Outcomes
Strengthening Social and Behavioral Science to Help Consumers and Professionals Make Informed Decisions About FDA Regulated Products
Strengthening Social and Behavioral Science at the FDA by Enhancing Audience Understanding
Development of a New Prevention-Focused Food Safety System
Strengthening the Global Product Safety Net
Development of a Medical Countermeasures Structure to Protect Against Threats
Advancing Regulatory Science for Public Health
The FDA outlines a broad vision for advancing regulatory science and unleashing its potential to improve public health.
View the report.
View speech by FDA Commissioner Margaret A. Hamburg, M.D (National Press Club, 10/6/10)
To read more about advancing Regulatory Science, visit the FDA's webpage.